Skip to main content
Erschienen in: Journal of Neurology 6/2010

01.06.2010 | Original Communication

The epidemiology of motor neurone disease in two counties in the southwest of England

verfasst von: Ibrahim Imam, Susan Ball, Dave Wright, C. Oliver Hanemann, John Zajicek

Erschienen in: Journal of Neurology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

The epidemiology of motor neurone disease (MND) in the counties of Devon and Cornwall in the southwest of England has not previously been studied. A previous study of England and Wales has, however, reported a very high death certification rate of MND in Devon. This study was carried out to establish the prevalence and incidence of MND in Devon and Cornwall and make comparisons with published rates in other populations. We attempted to identify all cases of MND diagnosed in Devon and Cornwall between 2002 and 2007. Case identification was centred on the major hospitals in the two counties and multiple sources of ascertainment were used. All identified cases had their case notes reviewed to establish the diagnosis and classify by type of MND. Point prevalence of MND was established for September 1st, 2007. The overall incidence rate standardised to the 2001 United Kingdom population was 2.52 per 100,000 (95% confidence interval 2.20–2.84). The incidence rate was significantly higher in males (P < 0.001). The estimated male to female incidence ratio was 2.10 (95% CI 1.61–2.73). The crude incidence rate in Cornwall was 3.78 per 100,000 (95% CI 3.03–4.53) and this was significantly higher (P = 0.011) than the rate in Devon, which was 2.61 per 100,000 (95% CI 2.19–3.04). The standardised incidence rate for the study period in Devon was 2.26 per 100,000 (95% CI 1.91–2.60) and in Cornwall it was 3.06 per 100,000 (95% CI 2.44–3.68). The overall standardised point prevalence rate was 5.66 per 100,000 (95% CI 4.49–6.83). The incidence rate of MND in our study is similar to reported findings in large prospective studies of the disease. There is a significant difference between the incidence rates in Devon and Cornwall. There is a need to establish a prospective MND Register to accurately document the epidemiological characteristics of the disease in the two counties.
Literatur
1.
Zurück zum Zitat Beghi E, Millul A, Micheli A, Vitelli E, Logrosconi G (2007) Incidence of ALS in Lombardy, Italy. Neurology 68:141–145CrossRefPubMed Beghi E, Millul A, Micheli A, Vitelli E, Logrosconi G (2007) Incidence of ALS in Lombardy, Italy. Neurology 68:141–145CrossRefPubMed
2.
Zurück zum Zitat Bonvicini F, Vinceti M, Marcello N, Rodolfi R, Rinaldi M (2008) The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Amyotroph Lateral Scler 9:350–353CrossRefPubMed Bonvicini F, Vinceti M, Marcello N, Rodolfi R, Rinaldi M (2008) The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Amyotroph Lateral Scler 9:350–353CrossRefPubMed
3.
Zurück zum Zitat Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR (1983) Motor neuron disease in England and Wales, 1959–1979. J Neurol Neurosurg Psychiatry 46:197–205CrossRefPubMed Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR (1983) Motor neuron disease in England and Wales, 1959–1979. J Neurol Neurosurg Psychiatry 46:197–205CrossRefPubMed
4.
Zurück zum Zitat Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy. Evidence for a uniform frequency in Western countries. Neurology 56:239–244 Piemonte and Valle d’Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy. Evidence for a uniform frequency in Western countries. Neurology 56:239–244
5.
Zurück zum Zitat Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP (1996) Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 60:147–151CrossRefPubMed Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP (1996) Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 60:147–151CrossRefPubMed
6.
Zurück zum Zitat Day TG, Scott M, Perring R, Doyle P (2007) Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975–2004. Amyotroph Lateral Scler 8:337–342CrossRefPubMed Day TG, Scott M, Perring R, Doyle P (2007) Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975–2004. Amyotroph Lateral Scler 8:337–342CrossRefPubMed
7.
Zurück zum Zitat Dean G, Quigley M, Goldacre M (1994) Motor neuron disease in a defined English population: estimates of incidence and mortality. J Neurol Neurosurg Psychiatry 57:450–454CrossRefPubMed Dean G, Quigley M, Goldacre M (1994) Motor neuron disease in a defined English population: estimates of incidence and mortality. J Neurol Neurosurg Psychiatry 57:450–454CrossRefPubMed
8.
Zurück zum Zitat Donaghy C, O’Toole O, Sheehan C, Kee F, Hardiman O, Patterson V (2009) An all-Ireland epidemiological study of MND, 2004–2005. Eur J Neurol 16:148–153CrossRefPubMed Donaghy C, O’Toole O, Sheehan C, Kee F, Hardiman O, Patterson V (2009) An all-Ireland epidemiological study of MND, 2004–2005. Eur J Neurol 16:148–153CrossRefPubMed
9.
Zurück zum Zitat Forbes RB, Colville S, Parratt J, Swingler RJ (2007) The incidence of motor neuron disease in Scotland. J Neurol 254:866–869CrossRefPubMed Forbes RB, Colville S, Parratt J, Swingler RJ (2007) The incidence of motor neuron disease in Scotland. J Neurol 254:866–869CrossRefPubMed
10.
Zurück zum Zitat Forsgren L, Almay BGL, Holmgren G, Wall S (1983) Epidemiology of motor neuron disease in Northern Sweden. Acta Neurol Scand 68:20–29CrossRefPubMed Forsgren L, Almay BGL, Holmgren G, Wall S (1983) Epidemiology of motor neuron disease in Northern Sweden. Acta Neurol Scand 68:20–29CrossRefPubMed
11.
Zurück zum Zitat Kahana E, Alter M, Feldman S (1976) Amyotrophic lateral sclerosis: a population study. J Neurol 212:205–213CrossRefPubMed Kahana E, Alter M, Feldman S (1976) Amyotrophic lateral sclerosis: a population study. J Neurol 212:205–213CrossRefPubMed
12.
Zurück zum Zitat Kahana E, Zilber N (1984) Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch Neurol 41:157–160PubMed Kahana E, Zilber N (1984) Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch Neurol 41:157–160PubMed
13.
Zurück zum Zitat Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, Lamberti P, Lepore V, Serlenga L (2005) Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 76:1094–1098CrossRefPubMed Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, Lamberti P, Lepore V, Serlenga L (2005) Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry 76:1094–1098CrossRefPubMed
14.
Zurück zum Zitat Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G (1998) Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiatry 65:842–847CrossRefPubMed Mitchell JD, Gatrell AC, Al-Hamad A, Davies RB, Batterby G (1998) Geographical epidemiology of residence of patients with motor neuron disease in Lancashire and south Cumbria. J Neurol Neurosurg Psychiatry 65:842–847CrossRefPubMed
15.
Zurück zum Zitat Mitchell JD, Gibson HN, Gatrell A (1990) Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976–1986. A geographical study. Arch Neurol 47:875–880PubMed Mitchell JD, Gibson HN, Gatrell A (1990) Amyotrophic lateral sclerosis in Lancashire and South Cumbria, England, 1976–1986. A geographical study. Arch Neurol 47:875–880PubMed
16.
Zurück zum Zitat Norris F, Shepherd R, Denys E, K U, Mukai E, Elias L, Holden D, Norris H (1993) Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 118:48–55CrossRefPubMed Norris F, Shepherd R, Denys E, K U, Mukai E, Elias L, Holden D, Norris H (1993) Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 118:48–55CrossRefPubMed
17.
Zurück zum Zitat O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O (2008) Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 79:30–32CrossRefPubMed O’Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, Hardiman O (2008) Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry 79:30–32CrossRefPubMed
18.
Zurück zum Zitat Swingler RJ, Fraser H, Warlow CP (1992) Motor neuron disease and polio in Scotland. J Neurol Neurosurg Psychiatry 55:1116–1120CrossRefPubMed Swingler RJ, Fraser H, Warlow CP (1992) Motor neuron disease and polio in Scotland. J Neurol Neurosurg Psychiatry 55:1116–1120CrossRefPubMed
19.
Zurück zum Zitat Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O (2007) Amyotrophic lateral scleroses mimic syndromes: a population-based study. Arch Neurol 57:109–113CrossRef Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O (2007) Amyotrophic lateral scleroses mimic syndromes: a population-based study. Arch Neurol 57:109–113CrossRef
20.
Zurück zum Zitat Vázquez MC, Ketzoián C, Legnani C, Rega I, Sánchez N, Perna A, Penela M, Aguirrezábal X, Druet-Cabanac M, Medici M (2008) Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology 30:105–111CrossRefPubMed Vázquez MC, Ketzoián C, Legnani C, Rega I, Sánchez N, Perna A, Penela M, Aguirrezábal X, Druet-Cabanac M, Medici M (2008) Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology 30:105–111CrossRefPubMed
21.
Zurück zum Zitat Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P, Lepore V, Serlenga L, Logroscino G (2006) Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci 250:45–94CrossRefPubMed Zoccolella S, Beghi E, Palagano G, Fraddosio A, Samarelli V, Lamberti P, Lepore V, Serlenga L, Logroscino G (2006) Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study. J Neurol Sci 250:45–94CrossRefPubMed
Metadaten
Titel
The epidemiology of motor neurone disease in two counties in the southwest of England
verfasst von
Ibrahim Imam
Susan Ball
Dave Wright
C. Oliver Hanemann
John Zajicek
Publikationsdatum
01.06.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 6/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-009-5448-0

Weitere Artikel der Ausgabe 6/2010

Journal of Neurology 6/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.